Red Cell Disorders Flashcards

1
Q

List the different causes/ mechanisms for haemolysis

A

Intrinsic causes

1) Enzymes
- G6PD
- PK deficiency
- P5N deficiency

2) Haemoglobin
- Haemoglobinopathies/ unstable haemoglobin (HbS, HbCS etc…)
- Thalassaemia

3) Membrane/ cytoskeleton
- Hereditary spherocytosis
- Hereditary elliptocytosis/ Hereditary pyropoikilocytosis
- South East Asian Ovalocytosis
- Hereditary Stomatocytosis
- PNH

Extrinsic causes

1) Immune
- Warm AIHA
- Cold AIHA
- PCH
- Alloimmune
- Drug induced

2) Non-immune
- Fragmentation haemolysis (TTP/HUS, DIC, HELLP, APLS, malignancy, medications, cardiac)
- Spur cell haemolysis
- Malaria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List the basic tests performed to assess for haemolysis and provide a brief description of how they are performed

A

1) Reticulocyte count (>250 highly specific)
- Manual method: supravital staining with new methylene blue or brilliant cresyl blue. 1000 RBCs counted to determine the %.
- Automated: fluorochromes bind to RNA. Fluorescent cells enumerated on flow cytometer
- Can be reported as reticulocytes %, absolute and corrected

2) Haptoglobins (acute phase reactant)
- Samples dispensed into wells on agarose gel that contain an antibody to haptoglobin.
- Precipitation rings form.
- The diameter of the ring is proportional to the concentration of haptoglobins.

3) LDH

4) DAT
- Antiglobulin reagent mixed with patient red cells.
- Antiglobulin bind to the immunoglobulin (or complement) on the sensitised cells causes agglutination

5) Urinary haemosiderin
- Urine centrifuged for 10-15 minutes
- Transferred onto a slide and air dried
- Slide fixed and stained with Perl’s stain and examined under the microscope.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List the tests that could be performed to diagnose hereditary spherocytosis?

A

1) Full blood count with reticulocyte count: anaemia, increased MCHC, increased reticulocytes.
2) Blood film: spherocytes, polychromasia.
3) Tests to confirm haemolysis: LDH (high), haptoglobins (low).
4) Exclude AIHA: DAT.

5) Osmotic fragility test:
- Spherocytes= SA:V at baseline, take on less volume before lysis.
- increasingly hypotonic solutions of saline are used: more hypotonic, more lysis.
- HS cells will lyse at NACL concentrations ≥5g/L.
- Curve shifts to the right.

6) Acidified glycerol test:
- Glycerol in a hypotonic saline solution slows RBC lysis enabling a more convenient measurement of lysis
- Lysis measured in a spectrometer at 625nm.
- In HS, range of AGLT50 is seconds to 2-3 minutes (normal >30 min).

7) EMA binding test
- EMA binds to band 3.
- Deficiency or abnormality in the band 3 protein will lead to reduced fluorescence.
- HS cells= decreased fluorescence.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Discuss hereditary elliptocytosis and HPP

A
  • Inherited disorder caused by mutations in spectrin.
  • Autosomal dominant inheritance.
  • Heterozygotes usually asymptomatic with mild compensated or no haemolysis.
  • Homozygotes and compound heterozygotes often have severe, symptomatic haemolytic anaemia (haemolytic HE or HPP)
  • HPP= most severe form of HE
  • HPP morphology: poikilocytes, spherocytes, microspherocytes, fragmentation. Elliptocytes uncommon. Extreme microcytosis, (MCV 30-50 fL), high MCHC.
  • Most often diagnosed by morphology
  • EMA binding can be used. Borderline reduced fluorescence in HE, markedly reduced fluorescence in HPP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Briefly describe the glycolytic, pentose phosphate and glutathione pathways and how they interact.

A
  • In order to function, red blood cells need an energy source in the form of ATP and a source of reducing power
  • ATP is generated via the glycolytic pathway
  • The reducing agent NADH and NADPH are generated via the glycolytic and pentose phosphate pathway respectively
  • NADH reduces metHb
  • NADPH reduces and detoxifies free radicals and hydrogen peroxide
  • NADPH also drives the glutathione pathway leading to the formation of the antioxidant GSSH
  • The pathways are linked: glucose is converted to G6P by hexokinase. G6P can be used in the glycolytic pathway to generate NAD and ATP or in the PPP to generate NADPH and activate the glutathione cycle
  • The glycolytic pathway is also linked to the Rapoport-Luebering shunt which produces 2,3-DPG which regulates the oxygen affinity of haemoglobin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Discuss PK deficiency

A
  • Pyruvate kinase converts phosphoenolpyruvate (PEP) to pyruvate which can then be converted to lactate by lactate dehydrogenase.
  • This reaction generates ATP from ADP and reduces NADH to NAD
  • PK deficiency is the most common enzymopathy of the glycolytic pathway.
  • Deficiencies in PK lead to a moderate to severe chronic non-spherocytic haemolytic anaemia.
  • FBC shows a moderate to severe normocytic anaemia with reticulocytosis +/- mild macrocytosis.
  • Blood film shows anisopoikilocytosis and reticulocytosis. Post splenectomy ‘prickle’ cells or spheroacanthocytes are seen.
  • Deficient activity of PK leads to an accumulation of upstream metabolites including 2,3-DPG.
  • This decreases oxygen affinity.
  • Can be tested for by the PK activity assay:
  • Get rid of WCC first: tests only in RBCs
  • PEP, ADP, NADH and LDH added so that test is dependent on PK
  • Absorbance measured at 340nm: absorbance will fall as NADH is converted to NAD.
  • Rate of fall of absorbance is proportional to the amount of PK present
  • Can also measure 2,3-DPG levels (which increase in PK deficiency) using a similar principle.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Discuss the tests used in the diagnosis of G6PD

A

Screening tests:

1) Supravital staining
- Using methyl violet, new methylene blue or brilliant cresyl blue.

2) Fluorescent screening/ fluorescent spot test
- NADPH produced by G6PD fluoresces under UV light: NADP does not
- G6P and NADP added to patients blood sample and placed on Whatman No1 filter.
- incubated for 10mins then examined under UV light
- No fluorescence: no G6PD

3) Methaemoglobin reduction test
- Sodium nitrate converts Hb to Hi
- Reduced back to Hb when methylene blue is added
- Colour change observed: clear red= normal; brown= deficient.

Diagnostic tests:

1) G6PD assay
- NADPH has a peak UV light absorption at 340nm whereas NADP does not
- Reaction kits containing NADP added to patients blood. The change in absorbance is then measured over the first 5 minutes of the reaction and the G6PD activity is determined by a formula.

2) Gene sequencing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Discuss some of the issues with G6PD testing

A
  • Gene for G6PD is on the X chromosome.
  • Males can be normal or deficient.
  • Females can be homozygous or heterozygous.
  • Due to inactivation of one of the X chromosomes, heterozygous female can have 20- 80% functioning G6PD. Can therefore be difficult to detect female heterozygotes.
  • Red cells are likely to haemolyse only if they have < 20% of the normal enzyme.
  • During an acute haemolytic episode the G6PD cells in a heterozygote may have undergone haemolysis leaving the G6PD sufficient cells when testing is undertaken
  • G6PD levels are highest in reticulocytes, samples taken during an acute haemolytic episode can have higher G6PD activity- even within the normal range.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the changes to haemoglobin synthesis and morphological appearances of red cells in lead poisoning

A
  • Lead inhibits most enzymes in the haem biosynthetic pathway: especially ALAD.
  • Lead also limits iron delivery to ferrochelatase (FECH) in erythroid cells. As a result, zinc is inserted into protoporphyrin, similar to the process that occurs in iron deficiency.
  • Lead is an inhibitor of pryimidine-5’-nucleotidase leading to an acquired deficiency of P5N.
  • Lead poisoning manifests with ineffective haematopoiesis and haemolysis as well as other manifestations in multiple organ systems.
  • Blood film features:
    • Normocytic and normochromic anaemia
    • Increased polychromasia
    • Nucleated red cells
    • Basophilic stippling
    • Bone marrow hypoplasia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Discuss how P5N deficiency is diagnosed

A
  • Normal nucleotide pool of RBCs is >95% purines with low levels of the pyrimidines (cytidine and uridine).
  • In P5N deficient cells >50% of this pool consists of pyrimidines.
  • In acidic solutions, cytidine has a maximum absorbance at 280nm whereas purines have a maximum absorbance at 260nm.
  • The ratio of absorbance at 260nm to 280mn is used to determine the amount of purines present compared to cytidine.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What haemoglobin variants run together on alkaline electrophoresis (cellulose acetate)?

A
  • SGD

- A2 CEO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What haemoglobin variants run together on acid electrophoresis (citrate agar)?

A
  • AGED Lepore
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What should a good thalassaemia antenatal screening programme achieve?

A

1) Detect couples at risk of a major thalassaemia disorder
- Identifies all couples with beta globin gene abnormalities
- Identifies all couples at risk of HbH disease and/ or Hb Barts hydrops (2 gene alpha thal, non-deletional alpha thal (CS))

2) Provides genetic counselling regarding phenotypes of thalassaemia and prenatal diagnosis
3) Identifies and counsels other family members at risk
4) Identifies and treats iron deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does antenatal screening for thalassaemia work?

A
  • FBC performed at time of booking
  • If thalassaemic indices present (particularly low MCV, low MCHC); iron studies and HbEp should be performed
  • If the female has any thing abnormal on this screen- the partner should also be screened with FBC, ferritin and HbEp
  • If the male and female are at risk of a major thalassaemic disorder based on the above tests then DNA confirmation is required.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why are at babies at risk of thalassaemia/ haemoglobinopathy screened at delivery?

A
  • Neonatal screening can be performed on a cord blood, capillary or venous sample.
  • Absent HbA= major thalassaemic disorder
  • HbA <10% possible beta thal trait
  • Variant haemoglobins may be detected
  • Hb Barts detected: alpha thalassaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Discuss the laboratory features of Beta Thalassaemia Major

A
  • Marked hypochromic, microcytic anaemia
  • Polychromasia, nucleated red cells, target cells and stippled cells on blood film
  • HPLC: dominant Hb is HbF with some HbA2. Minimal or no HbA.
  • Compound heterozygotes states will show HbF, variant Hb, no/ minimal HbA, variable A2
17
Q

List the thalassaemia’s/ haemoglobinopathies that can have a normal FBC

A
  • Single gene deleted alpha thalassaemia
  • Sickle cell trait
  • Heterozygous HbC, HbE, HbD, HbO
  • HPFH
18
Q

Discuss the diagnosis of alpha thalassaemia

A

Different results based on how many genes deleted and whether deletions occur in cis or trans

1) HbH cytochemical stain (detects HbH); will not detect single gene, variable with two gene deletions; more likely if cis)
2) Alpha thal ICT (detects Hb Barts); will detect two gene deletions and HbCS. Sometimes single gene.

3) HPLC
- Detect Hb Barts and HbH in those with HbH disease
- Detect Hb Barts in neonates with alpha thalssaemia
- May detect HbCS (fast moving, unstable band, difficult to detect on some analysers)

4) Genetic testing
- Gap PCR for most common variants
- Reserved for couples at high risk of HbH/ Hb Barts

19
Q

In those with beta chain disorders, what features may indicate an underlying alpha thalassaemia?

A
  • Ethnicity
  • In heterozygous state, variant haemoglobins often have normal MCV, MCH and MCHC. Consider alpha thal if these parameters are abnormal.
  • In the heterozygous state, Hb variant should comprise >40% of total Hb (HbA> Hb variant). If Hb variant is <39%, an underlying alpha thal should be considered.
20
Q

Discuss the diagnosis of beta thalassaemia trait

A
  • Red cell microcytosis, hypochromia +/- anaemia (mild if present)
  • Raised HbA2 on HPLC diagnostic. Variable HbF.
  • Gene sequencing can be performed in couples at high risk
21
Q

What is the difference between delta beta thalassaemia and hereditary persistence of fetal haemoglobin?

A
  • Both genetic disorders where there are deletions (of variable size and locations) involving the beta gene complex with elevated levels of HbF.
  • Distinguished based on clinical and haematological data
  • Deletional HPFH: HbF 15-30% with normal indices
  • Delta beta thalassaemia: HbF 5-20% with thalassaemic indices
  • Clinically significant thalassaemic conditions can occur with delta beta thal/ beta thal (thal intermedia) and delta beta thal/ HbS (mild sickling disorder)
22
Q

What is Haemoglobin Lepore?

A
  • Fusion between delta and beta genes
  • Results in reduced production of beta globin because the beta gene transcription comes under the control of the delta gene promotor.
  • Presents like beta thal clinically (trait when inherited in heterozygous form, intermedia or major when inherited in homozygous form)
  • As a fusion Hb product is formed: distinct band seen on HPLC
23
Q

List the compound heterozygous conditions that can lead to a clinically significant disorder when inherited with sickle cell trait

A
  • Beta thal (+ or 0)
  • HbC
  • HbO Arab
  • HbD Punjab/ Los angeles
  • Delta beta thalassaemia (generally mild)
  • Hb lepore (generally mild)
  • HbE (rare, generally mild)
24
Q

List the compound heterozygous conditions that can lead to a clinically significant disorder when inherited with beta thalassaemia

A
  • HbS
  • HbE
  • Delta beta thal
  • Hb lepore
  • HbO Arab (generally mild)
25
Q

Summarise the common features of HbE, HbC, HbO Arab and HbD Punjab

A
  • Asymptomatic and often haematologically silent when inherited in a heterozygous state
  • Clinically insignificant when inherited in the homozygous state
  • Heterozygotes= <50% Hb= Hb variant.
  • Relevance in heterozygotes and homozygous is reproductive
  • Can produce clinically significant sickling disorders when inherited with HbS (although very rare and mild with HbE)
  • Can produce clinically significant thalassaemic condition when inherited with beta thal (severity depends on amount of HbA present)
26
Q

What 5 factors influence the degree of sickling seen in HbS?

A

1) Deoxygenation
2) HbS concentration
3) Other Haemoglobin concentration (HbA, HbA2, HbF, HbC, HbO, HbD)
4) Temperature
5) Acidosis

27
Q

What tests are used to diagnose sickle cell

A
  • FBC indices
  • Blood film review
  • Sickling test (thin wet film of blood with a cover slip that is sealed with petroleum jelly or nail polish. Slide kept at 37 deg)
  • Solubility test (Blood mixed with phosphate buffer, allowed to stand for 5 minutes. Read for turbidity against a white card with narrow black lines. If the test is positive- centrifuge. A positive test will show a dark red band at the top whereas the solution below will be pink or colourless.)
  • HbEp: Migrates with D and G on alkaline electrophoresis. Migrates independently on acid electrophoresis.
  • HPLC: Abnormal band after A2
  • Genetic testing (not usually required)